Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs

 

• As part of the deal, Totality Medispa will pay Lilly a monetary payment and cease using Lilly's branding to promote its products.
• In April, U.S. District Judge ruled that Eli Lilly cannot rely on state law to stop a compounding pharmacy from marketing tirzepatide drugs.

https://www.benzinga.com/general/biotech/24/05/38845991/eli-lilly-strikes-deal-to-combat-counterfeit-diabetes-and-weight-loss-drugs-mounjaro-and-zepbound